Bupivacaine Liposome Injection T preparation + Bupivacaine Liposome Injection R preparation
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Postoperative Local Analgesia
Conditions
Postoperative Local Analgesia
Trial Timeline
Jun 9, 2025 → Jul 21, 2025
NCT ID
NCT07279155About Bupivacaine Liposome Injection T preparation + Bupivacaine Liposome Injection R preparation
Bupivacaine Liposome Injection T preparation + Bupivacaine Liposome Injection R preparation is a phase 1 stage product being developed by Jiangsu Hengrui Medicine for Postoperative Local Analgesia. The current trial status is completed. This product is registered under clinical trial identifier NCT07279155. Target conditions include Postoperative Local Analgesia.
What happened to similar drugs?
10 of 20 similar drugs in Postoperative Local Analgesia were approved
Approved (10) Terminated (1) Active (10)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07279155 | Phase 1 | Completed |
Competing Products
20 competing products in Postoperative Local Analgesia